Estados Unidos · Agencias y tiempo real · Bloomberg

EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen

Publicado por Bloomberg · Estados Unidos hace 2 h

EQT AB is nearing a deal to acquire Qiagen NV for around €9.6 billion ($10.8 billion) bringing an end to years of takeover speculation involving the European molecular testing…

Leer el artículo completo en Bloomberg Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.bloomberg.com)

EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen

También te puede interesar

Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026

Dan Gilbert pledges $1 billion to redevelop Detroit’s Renaissance Center

Accenture, Dragos and SANS Institute Launch Foundation to Strengthen Cyber Defenses for Under-Resourced U.S. Utilities

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows

EQT Nears €9.6 Billion Deal for Molecular Testing Firm Qiagen

Compartir

También te puede interesar

Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026

Dan Gilbert pledges $1 billion to redevelop Detroit’s Renaissance Center

Accenture, Dragos and SANS Institute Launch Foundation to Strengthen Cyber Defenses for Under-Resourced U.S. Utilities

Episode 49: Trump’s Tariffs Give Forced-Labor Activists an Opening

MT Newswires' MCP Server Now Available in Perplexity Computer, Bringing Real-Time Global Market News to AI-Driven Workflows